雍禾医疗集团有限公司是一家控股公司，专门从事提供毛发相关医疗服务。该公司提供一站式毛发医疗 服务，涵盖植发医疗、医疗养固、常规养护及其他配套服务。该公司构建了以"雍禾医疗"为核心，由专 业植发品牌"雍禾植发"、医疗养固品牌"史云逊"、女性美学植发品牌"雍禾发之初"，及医学假发品 牌"哈发达"等组成的全产业链品牌矩阵。该公司建立独立的史云逊医学健发中心，为被毛发问题困扰的 患者进行医学检测、诊断与个性化护理治疗，以提供更专业的医疗毛发健康管理服务。该公司主要在中 国国内市场开展业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，12月9日南向资金减持5000.0股雍禾医疗（02279.HK）。近5个交易日中，获南向资金减 持的有5天，累计净减持4.7万股。近20个交易日中，获南向资金减持的有20天，累计净减持51.35万股。 截至目前，南向资金持有雍禾医疗（02279.HK）1641.2万股，占公司已发行普通股的3.12%。 ...

Core Viewpoint - Southbound funds have reduced their holdings in Yonghe Medical (02279.HK) by 1,000 shares on November 18, 2025, marking a continued trend of net reductions over recent trading days [1] Group 1: Shareholding Changes - In the last 5 trading days, Southbound funds have reduced their holdings for 5 days, with a total net reduction of 41,500 shares [1] - Over the last 20 trading days, Southbound funds have reduced their holdings for all 20 days, with a cumulative net reduction of 842,000 shares [1] - As of now, Southbound funds hold 16.711 million shares of Yonghe Medical, representing 3.17% of the company's total issued ordinary shares [1] Group 2: Company Overview - Yonghe Medical Group Limited is a holding company specializing in hair-related medical services, offering a one-stop solution that includes hair transplant medical services, medical hair care, routine maintenance, and other supporting services [2] - The company has established a brand matrix centered around "Yonghe Medical," which includes professional hair transplant brand "Yonghe Hair Transplant," medical hair care brand "Shiyunxun," female aesthetic hair transplant brand "Yonghe Fazhichu," and medical wig brand "Hafada" [2] - Yonghe Medical operates primarily in the domestic market of China, providing specialized medical hair health management services through its independent Shiyunxun Medical Hair Care Center [2]

Core Insights - Southbound funds have reduced their holdings in Yonghe Medical (02279.HK) by 1,000 shares on November 6, 2025, marking a continuous reduction over the past five trading days with a total net reduction of 163,500 shares [1] - Over the last 20 trading days, there has been a total net reduction of 1,128,500 shares, indicating a consistent trend of selling by southbound funds [1] - As of now, southbound funds hold 16,842,500 shares of Yonghe Medical, which represents 3.19% of the company's total issued ordinary shares [1] Shareholding Changes - On November 6, 2025, the total number of shares held was 16,842,500, with a decrease of 1,000 shares, reflecting a change of -0.01% [2] - On November 5, 2025, the total number of shares held was 16,843,500, with a decrease of 82,000 shares, reflecting a change of -0.48% [2] - On November 3, 2025, the total number of shares held was 16,925,500, with a decrease of 10,500 shares, reflecting a change of -0.06% [2] - On October 31, 2025, the total number of shares held was 16,936,000, with a decrease of 28,500 shares, reflecting a change of -0.17% [2] - On October 23, 2025, the total number of shares held was 16,964,500, with a decrease of 41,500 shares, reflecting a change of -0.24% [2] Company Overview - Yonghe Medical Group Limited is a holding company specializing in providing hair-related medical services, offering a one-stop solution that includes hair transplant medical services, medical hair care, routine maintenance, and other supporting services [2] - The company has established a brand matrix centered around "Yonghe Medical," which includes specialized hair transplant brand "Yonghe Hair Transplant," medical hair care brand "Shiyunxun," female aesthetic hair transplant brand "Yonghe Hair Origin," and medical wig brand "Hafada" [2] - Yonghe Medical has set up independent Shiyunxun Medical Hair Care Centers to provide medical testing, diagnosis, and personalized care treatment for patients troubled by hair issues, aiming to deliver more professional medical hair health management services [2]

Core Viewpoint - Southbound funds have significantly reduced their holdings in Yonghe Medical (02279.HK), indicating a potential shift in investor sentiment towards the company [1][2]. Group 1: Shareholding Changes - On October 21, 2025, southbound funds reduced their holdings by 126,000 shares, representing a decrease of 0.74% [2]. - Over the past five trading days, there has been a cumulative net reduction of 461,000 shares, with reductions occurring on five separate days [1]. - In the last twenty trading days, the total net reduction reached 1,067,000 shares, with reductions on all twenty days [1]. Group 2: Current Holdings - As of now, southbound funds hold 17,006,000 shares of Yonghe Medical, which accounts for 3.22% of the company's total issued ordinary shares [1]. Group 3: Company Overview - Yonghe Medical Group Limited is a holding company specializing in hair-related medical services, offering a comprehensive range of services including hair transplant medical care, medical hair maintenance, routine care, and other supporting services [2]. - The company has established a brand matrix centered around "Yonghe Medical," which includes specialized brands such as "Yonghe Hair Transplant," "Shiyunxun" for medical hair maintenance, "Yonghe Hair Origin" for female aesthetic hair transplant, and "Hafada" for medical wigs [2]. - Yonghe Medical primarily operates in the domestic market of China, providing professional medical hair health management services through its independent Shiyunxun Medical Hair Health Center [2].

Group 1 - The core point of the article highlights the recent reduction in holdings of Yonghe Medical (02279.HK) by southbound funds, with a total net reduction of 139,000 shares over the last 20 trading days [1][2] - As of October 15, 2025, southbound funds hold 17,409,000 shares of Yonghe Medical, representing 3.31% of the company's total issued ordinary shares [1][2] - The company has experienced a consistent trend of share reduction, with southbound funds reducing their holdings for five consecutive days, totaling a decrease of 55,000 shares on October 15, 2025 [1][2] Group 2 - Yonghe Medical Group Limited specializes in providing hair-related medical services, including hair transplant medical services, medical hair care, routine maintenance, and other supporting services [2] - The company has established a comprehensive brand matrix centered around "Yonghe Medical," which includes specialized brands for hair transplant, medical hair care, and aesthetic hair transplant services [2] - Yonghe Medical primarily operates in the domestic market of China, focusing on professional medical hair health management services [2]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Yonghe Medical (02279.HK) by 12,000 shares on September 19, 2025, marking a total net reduction of 257,500 shares over the past five trading days and 1,214,000 shares over the past 20 trading days [1][2] - As of now, southbound funds hold 17,722,000 shares of Yonghe Medical, which accounts for 3.37% of the company's total issued ordinary shares [1][2] Group 2 - Yonghe Medical Group Limited is a holding company specializing in providing hair-related medical services, offering a one-stop solution that includes hair transplant medical services, medical hair care, routine maintenance, and other supporting services [2] - The company has established a brand matrix centered around "Yonghe Medical," which includes professional hair transplant brand "Yonghe Hair Transplant," medical hair care brand "Shiyunxun," female aesthetic hair transplant brand "Yonghe Hair Origin," and medical wig brand "Hafada" [2] - Yonghe Medical operates primarily in the domestic market of China, providing specialized medical hair health management services through its independent Shiyunxun Medical Hair Care Center [2]

Core Viewpoint - Yonghe Medical (02279) reported a total revenue of 1.806 billion yuan for the fiscal year 2024, reflecting a year-on-year growth of 1.5%, while the net profit attributable to shareholders was a loss of 226 million yuan, an improvement from a loss of 546 million yuan in the previous year [3] Financial Performance - The company achieved a net cash flow from operating activities of 229 million yuan, compared to a negative 17.15 million yuan in the same period last year [3] - Basic earnings per share were reported at -0.45 yuan, with a weighted average return on equity of -26.99% [3][25] - As of April 29, the price-to-book ratio (TTM) was approximately 0.67 times, and the price-to-sales ratio (TTM) was about 0.26 times [3] Revenue Composition - In 2024, the revenue composition included 1.3307 billion yuan from hair transplant medical services and 445.8 million yuan from medical hair care services [20] - The company operates a full industry chain brand matrix centered around "Yonghe Medical," including specialized brands for hair transplant and medical hair care [13] Cash Flow and Financing - The net cash flow from financing activities was -291 million yuan, a decrease of 106 million yuan year-on-year, while the net cash flow from investment activities was -53.26 million yuan, compared to 246 million yuan in the previous year [29] Asset and Liability Changes - As of the end of 2024, the company's right-of-use assets decreased by 37.93%, while cash and cash equivalents decreased by 18.27% [37] - The company's lease liabilities decreased by 39.62%, and short-term borrowings decreased by 67.25% [40] - The current ratio was reported at 1.15, and the quick ratio was 1.08 [43]